Status:
RECRUITING
Development of Novel Gastric Cancer Screening and Diagnosis Technologies Using Tongue Imaging and Study of Tongue Image Changes Mechanisms
Lead Sponsor:
Zhejiang Cancer Hospital
Collaborating Sponsors:
Sichuan Cancer Hospital and Research Institute
The First Affiliated Hospital of Zhejiang Chinese Medical University
Conditions:
Gastric Cancer
Tongue Images
Eligibility:
All Genders
18-90 years
Brief Summary
In this study, the investigators will prospectively recruit 100,000 individuals, including gastric cancer patients who have not undergone any anti-tumor treatment and non-gastric cancer participants. ...
Detailed Description
Patients with gastric cancer were recruited through outpatient clinics, endoscopy units, and inpatient departments of various centers, with all patients requiring a histopathological diagnosis. Non-ga...
Eligibility Criteria
Inclusion
- Inclusion Criteria for Gastric Cancer Patients:
- 18≤age≤90
- Histologically or cytologically confirmed gastric cancer
- No prior chemotherapy, radiotherapy, biotherapy, immunotherapy or other anti-tumor treatment for gastric cancer
- Subject volunteers to join the study, Signs informed consent, has good compliance and can cooperate with follow-up
- Exclusion Criteria for Gastric Cancer Patients:
- Two or more kinds of malignant tumors at the same time
- Gastric cancer that has been treated by chemotherapy, radiotherapy, biotherapy, immunotherapy or other anti-tumor therapy
- The use of glucocorticoids and antibiotics in the past three months
- History of long-term medication
- Presence of oral diseases such as tooth and gum diseases
- Subjects who had other factors that might force them to terminate the research ahead of time, such as the development of other severe disease (including mental disease) that required combined treatment, seriously abnormal laboratory examination value, and family or social factors that might affect the subject safety or experimental data collection, as judged by the researchers
- Inclusion Criteria for Healthy Participants:
- 18≤age≤90
- Willingness to participate in the study, signing an informed consent form, and demonstrating good compliance
- Exclusion Criteria for Healthy Participants:
- History of malignant tumors
- The use of glucocorticoids and antibiotics in the past three months
- History of long-term medication
- Presence of oral diseases such as tooth and gum diseases
- Subjects who had other factors that might force them to terminate the research ahead of time, such as the development of other severe disease (including mental disease) that required combined treatment, seriously abnormal laboratory examination value, and family or social factors that might affect the subject safety or experimental data collection, as judged by the researchers
Exclusion
Key Trial Info
Start Date :
June 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
100000 Patients enrolled
Trial Details
Trial ID
NCT06078930
Start Date
June 1 2021
End Date
December 31 2026
Last Update
June 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zhejiang Cancer Hospital
Hangzhou, Zhejiang, China, 310022